Skip to main content
  • Subscribe to our new MS newsletter

    Subscribe to our new MS newsletter

    Subscribe to our free Multiple Sclerosis newsletter to learn more about MS treatments, research, clinical trials, our providers, and more.

    Subscribe here.

     

Multiple Sclerosis & Neuroimmunology

MS clinic

The Multiple Sclerosis Clinic at Duke provides excellent patient care as well as clinical and basic research concerning immune diseases of the central nervous system. All of our providers have been named MS Certified Specialists by the Consortium of MS Centers.

Our providers have experience with a variety of injectable, oral, and infusion treatments for MS. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.

Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.

Latest News

News  -  Epilepsy & Sleep, Multiple Sclerosis & Neuroimmunology, Clinical Neurophysiology, Neuromuscular Medicine/EMG

Husain, Neurology faculty shine at ICCN

Friday, May 4, 2018
The International Congress of Clinical Neurophysiology (ICCN) held its 31st meeting in Washington, DC, last week, thanks to the work and leadership...Read more
News  -  Epilepsy & Sleep, General & Community Neurology, Multiple Sclerosis & Neuroimmunology, Neuromuscular Disease, Stroke and Vascular Neurology, , Neuromuscular Medicine/EMG, Residency Program

Duke Neurology at AAN 2018: Highlights from Los Angeles

Friday, April 27, 2018
Members of the Duke Neurology Department advanced the field of neurology in areas from autoimmunity to improving participation multiple sclerosis...Read more